BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zou Z, Zhang HL, Roditi GH, Leiner T, Kucharczyk W, Prince MR. Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging 2011;4:1206-16. [PMID: 22093272 DOI: 10.1016/j.jcmg.2011.08.013] [Cited by in Crossref: 70] [Cited by in F6Publishing: 57] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Martin DR, Kalb B, Mittal A, Salman K, Vedantham S, Mittal PK. No Incidence of Nephrogenic Systemic Fibrosis after Gadobenate Dimeglumine Administration in Patients Undergoing Dialysis or Those with Severe Chronic Kidney Disease. Radiology 2018;286:113-9. [DOI: 10.1148/radiol.2017170102] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
2 Dilsizian V, Gewirtz H, Paivanas N, Kitsiou AN, Hage FG, Crone NE, Schwartz RG. Serious and potentially life threatening complications of cardiac stress testing: Physiological mechanisms and management strategies. J Nucl Cardiol 2015;22:1198-213. [DOI: 10.1007/s12350-015-0141-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 12] [Article Influence: 4.1] [Reference Citation Analysis]
3 Becker S, Walter S, Witzke O, Körber A, Bienholz A, Kottmann T, Kribben A, Kaiser G, Mitchell A. Edema, Hyperpigmentation, Induration: 3 Skin Signs Heralding Danger in Patients on Maintenance Hemodialysis. Medicine (Baltimore) 2016;95:e3121. [PMID: 27015187 DOI: 10.1097/MD.0000000000003121] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Fratz S, Chung T, Greil GF, Samyn MM, Taylor AM, Valsangiacomo Buechel ER, Yoo SJ, Powell AJ. Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease. J Cardiovasc Magn Reson. 2013;15:51. [PMID: 23763839 DOI: 10.1186/1532-429x-15-51] [Cited by in Crossref: 230] [Cited by in F6Publishing: 93] [Article Influence: 25.6] [Reference Citation Analysis]
5 Masci PG, Bogaert J. Post myocardial infarction of the left ventricle: the course ahead seen by cardiac MRI. Cardiovasc Diagn Ther. 2012;2:113-127. [PMID: 24282705 DOI: 10.3978/j.issn.2223-3652.2012.04.06] [Cited by in F6Publishing: 12] [Reference Citation Analysis]
6 Lunyera J, Mohottige D, Alexopoulos AS, Campbell H, Cameron CB, Sagalla N, Amrhein TJ, Crowley MJ, Dietch JR, Gordon AM, Kosinski AS, Cantrell S, Williams JW Jr, Gierisch JM, Ear B, Goldstein KM. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. Ann Intern Med 2020;173:110-9. [PMID: 32568573 DOI: 10.7326/M20-0299] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
7 Davies J, Siebenhandl-Wolff P, Tranquart F, Jones P, Evans P. Gadolinium: pharmacokinetics and toxicity in humans and laboratory animals following contrast agent administration. Arch Toxicol 2022. [PMID: 34997254 DOI: 10.1007/s00204-021-03189-8] [Reference Citation Analysis]
8 Padmanabhan A, Connelly-Smith L, Aqui N, Balogun RA, Klingel R, Meyer E, Pham HP, Schneiderman J, Witt V, Wu Y, Zantek ND, Dunbar NM, Schwartz GEJ. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue. J Clin Apher. 2019;34:171-354. [PMID: 31180581 DOI: 10.1002/jca.21705] [Cited by in Crossref: 314] [Cited by in F6Publishing: 277] [Article Influence: 104.7] [Reference Citation Analysis]
9 Farmakis SG, Khanna G. Extracardiac applications of MR blood pool contrast agent in children. Pediatr Radiol 2014;44:1598-609. [DOI: 10.1007/s00247-014-3167-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
10 Robles NR. [Atherosclerotic ischemic renal disease: clinical challenges]. Med Clin (Barc) 2015;144:163-5. [PMID: 25433792 DOI: 10.1016/j.medcli.2014.09.016] [Reference Citation Analysis]
11 Cheong BY, Duran C, Preventza OA, Muthupillai R. Comparison of Low-Dose Higher-Relaxivity and Standard-Dose Lower-Relaxivity Contrast Media for Delayed-Enhancement MRI: A Blinded Randomized Crossover Study. AJR Am J Roentgenol 2015;205:533-9. [PMID: 26295638 DOI: 10.2214/AJR.14.13749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
12 An FF, Chan M, Kommidi H, Ting R. Dual PET and Near-Infrared Fluorescence Imaging Probes as Tools for Imaging in Oncology. AJR Am J Roentgenol 2016;207:266-73. [PMID: 27223168 DOI: 10.2214/AJR.16.16181] [Cited by in Crossref: 29] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
13 Viallon M, Cuvinciuc V, Delattre B, Merlini L, Barnaure-Nachbar I, Toso-Patel S, Becker M, Lovblad KO, Haller S. State-of-the-art MRI techniques in neuroradiology: principles, pitfalls, and clinical applications. Neuroradiology 2015;57:441-67. [PMID: 25859832 DOI: 10.1007/s00234-015-1500-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 7.1] [Reference Citation Analysis]
14 Alabousi M, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training. Radiology 2021;300:279-84. [PMID: 34060939 DOI: 10.1148/radiol.2021210044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bruce R, Wentland AL, Haemel AK, Garrett RW, Sadowski DR, Djamali A, Sadowski EA. Incidence of Nephrogenic Systemic Fibrosis Using Gadobenate Dimeglumine in 1423 Patients With Renal Insufficiency Compared With Gadodiamide. Invest Radiol. 2016;51:701-705. [PMID: 26885631 DOI: 10.1097/rli.0000000000000259] [Cited by in Crossref: 34] [Cited by in F6Publishing: 16] [Article Influence: 6.8] [Reference Citation Analysis]
16 Kanakia S, Toussaint J, Hoang DM, Mullick Chowdhury S, Lee S, Shroyer KR, Moore W, Wadghiri YZ, Sitharaman B. Towards An Advanced Graphene-Based Magnetic Resonance Imaging Contrast Agent: Sub-acute Toxicity and Efficacy Studies in Small Animals. Sci Rep 2015;5:17182. [PMID: 26625867 DOI: 10.1038/srep17182] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 2.9] [Reference Citation Analysis]
17 Zhang R, Rose WN. Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis. Case Rep Dermatol Med. 2017;2017:3240287. [PMID: 28695022 DOI: 10.1155/2017/3240287] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Yan C, Hu J, Li Y, Xie X, Zou Z, Deng Q, Zhou X, Bi X, Zeng M, Liu J. Motion-corrected free-breathing late gadolinium enhancement combined with a gadolinium contrast agent with a high relaxation rate: an optimized cardiovascular magnetic resonance examination protocol. J Int Med Res 2020;48:300060520964664. [PMID: 33111603 DOI: 10.1177/0300060520964664] [Reference Citation Analysis]
19 Ramalho J, Ramalho M, Jay M, Burke LM, Semelka RC. Gadolinium toxicity and treatment. Magn Reson Imaging. 2016;34:1394-1398. [PMID: 27693607 DOI: 10.1016/j.mri.2016.09.005] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 10.2] [Reference Citation Analysis]
20 Tsuchida Y, Takata T, Ikarashi T, Iino N, Kazama JJ, Narita I. Dialysis disequilibrium syndrome induced by neoplastic meningitis in a patient receiving maintenance hemodialysis. BMC Nephrol 2013;14:255. [PMID: 24238645 DOI: 10.1186/1471-2369-14-255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Radiology 2021;298:28-35. [PMID: 33170103 DOI: 10.1148/radiol.2020202903] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
22 Christie A, Roditi G. Vascular imaging: the evolving role of the multidisciplinary team meeting in peripheral vascular disease. Semin Intervent Radiol 2014;31:320-9. [PMID: 25435657 DOI: 10.1055/s-0034-1393968] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
23 Kartamihardja AAP, Tsushima Y. The extra miles on preventing nephrogenic systemic fibrosis. Quant Imaging Med Surg 2019;9:1911-3. [PMID: 31867242 DOI: 10.21037/qims.2019.09.17] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Cubero-Gómez JM, Guerrero Márquez FJ, Diaz-de la-Llera L, Fernández-Quero M, Guisado-Rasco A, Villa-Gil-Ortega M. Severe thrombocytopenia induced by iodinated contrast after coronary angiography: The use of gadolinium contrast and intravascular ultrasound as an alternative to guide percutaneous coronary intervention. Rev Port Cardiol 2017;36:61.e1-4. [PMID: 27986390 DOI: 10.1016/j.repc.2016.04.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Malikova H. Nephrogenic systemic fibrosis: the end of the story? Quant Imaging Med Surg 2019;9:1470-4. [PMID: 31559176 DOI: 10.21037/qims.2019.07.11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
26 Zhang Q, Dai X, Zhang H, Zeng Y, Luo K, Li W. Recent advances in development of nanomedicines for multiple sclerosis diagnosis. Biomed Mater 2021;16:024101. [PMID: 33472182 DOI: 10.1088/1748-605X/abddf4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Lim J, Turkbey B, Bernardo M, Bryant LH Jr, Garzoni M, Pavan GM, Nakajima T, Choyke PL, Simanek EE, Kobayashi H. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics. Bioconjug Chem 2012;23:2291-9. [PMID: 23035964 DOI: 10.1021/bc300461r] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
28 Chang D, Wang Y, Zhang S, Bai Y, Liu D, Zang F, Wang G, Wang B, Ju S. Visualizing myocardial inflammation in a rat model of type 4 cardiorenal syndrome by dual-modality molecular imaging. Biomaterials 2015;68:67-76. [DOI: 10.1016/j.biomaterials.2015.07.050] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
29 Khor LK, Tan KB, Loi HY, Lu S. Nephrogenic Systemic Fibrosis in a Patient With Renal Failure Demonstrating a “Reverse Superscan” on Bone Scintigraphy. Clinical Nuclear Medicine 2013;38:203-4. [DOI: 10.1097/rlu.0b013e31827a22ae] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Xing X, Zeng X, Li X, Zhao Q, Kirchin MA, Pirovano G, Wang X, Li Y, Iezzi R, De Cobelli F. Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications? Radiol med 2015;120:239-50. [DOI: 10.1007/s11547-014-0434-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
31 Zamora CA, Castillo M. Historical Perspective of Imaging Contrast Agents. Magn Reson Imaging Clin N Am 2017;25:685-96. [PMID: 28964458 DOI: 10.1016/j.mric.2017.06.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Kramer CM, Chandrashekhar Y, Narula J. T1 Mapping by CMR in Cardiomyopathy: A Noninvasive Myocardial Biopsy? JACC: Cardiovascular Imaging 2013;6:532-4. [DOI: 10.1016/j.jcmg.2013.02.002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
33 Hurley MC, Soltanolkotabi M, Ansari S. Neuroimaging in acute stroke: choosing the right patient for neurointervention. Tech Vasc Interv Radiol 2012;15:19-32. [PMID: 22464299 DOI: 10.1053/j.tvir.2011.12.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
34 Lyapustina T, Goldfine C, Rhyee S, Babu KM, Griswold MK. Evaluating the Patient with Reported Gadolinium-Associated Illness. J Med Toxicol 2019;15:36-44. [PMID: 30499040 DOI: 10.1007/s13181-018-0689-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
35 Zhang B, Liang L, Chen W, Liang C, Zhang S. An Updated Study to Determine Association between Gadolinium-Based Contrast Agents and Nephrogenic Systemic Fibrosis. PLoS One 2015;10:e0129720. [PMID: 26076348 DOI: 10.1371/journal.pone.0129720] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
36 Pasquini L, Napolitano A, Visconti E, Longo D, Romano A, Tomà P, Rossi Espagnet MC. Gadolinium-Based Contrast Agent-Related Toxicities. CNS Drugs 2018;32:229-40. [PMID: 29508245 DOI: 10.1007/s40263-018-0500-1] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 11.3] [Reference Citation Analysis]
37 Cahalane AM, Kearney H, Purcell YM, Mcguigan C, Killeen RP. MRI and multiple sclerosis––the evolving role of MRI in the diagnosis and management of MS: the radiologist’s perspective. Ir J Med Sci 2018;187:781-7. [DOI: 10.1007/s11845-017-1714-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
38 Galperin TA, Cronin AJ, Leslie KS. Cutaneous manifestations of ESRD. Clin J Am Soc Nephrol. 2014;9:201-218. [PMID: 24115194 DOI: 10.2215/cjn.05900513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
39 van Oorschot JW, El Aidi H, Jansen of Lorkeers SJ, Gho JM, Froeling M, Visser F, Chamuleau SA, Doevendans PA, Luijten PR, Leiner T, Zwanenburg JJ. Endogenous assessment of chronic myocardial infarction with T(1ρ)-mapping in patients. J Cardiovasc Magn Reson 2014;16:104. [PMID: 25526973 DOI: 10.1186/s12968-014-0104-y] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
40 Wang J, Yan F, Liu J, Lu J, Li D, Luan J, Wang X, Li Y, Iezzi R, De Cobelli F. Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study). J Magn Reson Imaging 2013;38:926-37. [PMID: 23371919 DOI: 10.1002/jmri.24040] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
41 Velasco C, Cruz G, Lavin B, Hua A, Fotaki A, Botnar RM, Prieto C. Simultaneous T1 , T2 , and T cardiac magnetic resonance fingerprinting for contrast agent-free myocardial tissue characterization. Magn Reson Med 2021. [PMID: 34799854 DOI: 10.1002/mrm.29091] [Reference Citation Analysis]
42 Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, Dunbar NM, Witt V, Wu Y, Shaz BH. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue. J Clin Apher. 2016;31:149-162. [PMID: 27322218 DOI: 10.1002/jca.21470] [Cited by in Crossref: 168] [Cited by in F6Publishing: 216] [Article Influence: 33.6] [Reference Citation Analysis]
43 Weinreb JC, Rodby RA, Yee J, Wang CL, Fine D, McDonald RJ, Perazella MA, Dillman JR, Davenport MS. Use of Intravenous Gadolinium-Based Contrast Media in Patients With Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation. Kidney Med 2021;3:142-50. [PMID: 33604544 DOI: 10.1016/j.xkme.2020.10.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
44 To ACY, Schoenhagen P, Desai MY. Role of tomographic imaging in preoperative planning and postoperative assessment in cardiovascular surgery. Heart 2013;99:1048-60. [DOI: 10.1136/heartjnl-2012-301751] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
45 Janus N, Launay-Vacher V, Deray G. [Non-iodinated contrast media nephrotoxicity]. Nephrol Ther 2018;14:484-90. [PMID: 30301611 DOI: 10.1016/j.nephro.2018.09.002] [Reference Citation Analysis]
46 Blaha T, Nigwekar S, Combs S, Kaw U, Krishnappa V, Raina R. Dermatologic manifestations in end stage renal disease. Hemodial Int 2019;23:3-18. [PMID: 30520561 DOI: 10.1111/hdi.12689] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
47 van Oorschot JW, Visser F, Eikendal AL, Vonken EP, Luijten PR, Chamuleau SA, Leiner T, Zwanenburg JJ. Single Breath-Hold T1ρ-Mapping of the Heart for Endogenous Assessment of Myocardial Fibrosis. Invest Radiol 2016;51:505-12. [DOI: 10.1097/rli.0000000000000261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
48 Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ. Gadolinium-based contrast agents: A comprehensive risk assessment. J Magn Reson Imaging 2017;46:338-53. [PMID: 28083913 DOI: 10.1002/jmri.25625] [Cited by in Crossref: 168] [Cited by in F6Publishing: 132] [Article Influence: 33.6] [Reference Citation Analysis]
49 Ruberg FL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012;126:1286-1300. [PMID: 22949539 DOI: 10.1161/circulationaha.111.078915] [Cited by in Crossref: 328] [Cited by in F6Publishing: 148] [Article Influence: 32.8] [Reference Citation Analysis]
50 Thomson LK, Thomson PC, Kingsmore DB, Blessing K, Daly CD, Cowper SE, Roditi GH. Diagnosing nephrogenic systemic fibrosis in the post-FDA restriction era: NSF in the Post-FDA Restriction ERA. J Magn Reson Imaging 2015;41:1268-71. [DOI: 10.1002/jmri.24664] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
51 Chaaban N, Kshatriya S. The Role of Imaging in Diagnosing Transthyretin Cardiac Amyloidosis. Cureus 2021;13:e15468. [PMID: 34262806 DOI: 10.7759/cureus.15468] [Reference Citation Analysis]
52 Sabach AS, Bruno M, Kim D, Mulholland T, Lee L, Kaura S, Lim RP. Gadofosveset trisodium: abdominal and peripheral vascular applications. AJR Am J Roentgenol 2013;200:1378-86. [PMID: 23701079 DOI: 10.2214/AJR.12.8991] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
53 Coelho DH, Tang Y, Suddarth B, Mamdani M. MRI surveillance of vestibular schwannomas without contrast enhancement: Clinical and economic evaluation: Tumor Surveillance Without Contrast. The Laryngoscope 2018;128:202-9. [DOI: 10.1002/lary.26589] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 4.4] [Reference Citation Analysis]
54 Attari H, Cao Y, Elmholdt TR, Zhao Y, Prince MR. A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis. Radiology. 2019;292:376-386. [PMID: 31264946 DOI: 10.1148/radiol.2019182916] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 14.3] [Reference Citation Analysis]
55 Bauman G, Eichinger M. Ventilation and perfusion magnetic resonance imaging of the lung. Pol J Radiol 2012;77:37-46. [PMID: 22802864 DOI: 10.12659/pjr.882579] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
56 Rabbat MG, Kwong RY, Heitner JF, Young AA, Shanbhag SM, Petersen SE, Selvanayagam JB, Berry C, Nagel E, Heydari B, Maceira AM, Shenoy C, Dyke C, Bilchick KC; Society for Cardiovascular Magnetic Resonance. The Future of Cardiac Magnetic Resonance Clinical Trials. JACC Cardiovasc Imaging 2021:S1936-878X(21)00719-1. [PMID: 34922874 DOI: 10.1016/j.jcmg.2021.07.029] [Reference Citation Analysis]
57 Weyker PD, Pérez XL, Liu KD. Management of Acute Kidney Injury and Acid-Base Balance in the Septic Patient. Clin Chest Med 2016;37:277-88. [PMID: 27229644 DOI: 10.1016/j.ccm.2016.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
58 Halteh P, Huang J, Wildman HF, Magro CM. Gadolinium-Naive Nephrogenic Systemic Fibrosis of Breast Mimicking Inflammatory Breast Carcinoma. The American Journal of Dermatopathology 2017;39:322-4. [DOI: 10.1097/dad.0000000000000772] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Sirin S, Kathemann S, Schweiger B, Hahnemann ML, Forsting M, Lauenstein TC, Kinner S. Magnetic resonance colonography including diffusion-weighted imaging in children and adolescents with inflammatory bowel disease: do we really need intravenous contrast? Invest Radiol. 2015;50:32-39. [PMID: 25215934 DOI: 10.1097/rli.0000000000000092] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
60 van den Bosch H, Westenberg J, Setz-Pels W, Kersten E, Tielbeek A, Duijm L, Post J, Teijink J, de Roos A. Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study. Int J Cardiovasc Imaging 2016;32:1281-8. [PMID: 27209283 DOI: 10.1007/s10554-016-0908-y] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
61 Riser BL, Bhagavathula N, Perone P, Garchow K, Xu Y, Fisher GJ, Najmabadi F, Attili D, Varani J. Gadolinium-induced fibrosis is counter-regulated by CCN3 in human dermal fibroblasts: a model for potential treatment of nephrogenic systemic fibrosis. J Cell Commun Signal 2012;6:97-105. [PMID: 22648571 DOI: 10.1007/s12079-012-0164-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
62 Blom KB, Bergo KK, Espe EKS, Rosseland V, Grøtta OJ, Mjøen G, Åsberg A, Bergan S, Sanner H, Bergersen TK, Bjørnerheim R, Skauby M, Seljeflot I, Waldum-Grevbo B, Dahle DO, Sjaastad I, Birkeland JA. Cardiovascular rEmodelling in living kidNey donorS with reduced glomerular filtration rate: rationale and design of the CENS study. Blood Press 2020;29:123-34. [PMID: 31718316 DOI: 10.1080/08037051.2019.1684817] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]